Source:http://linkedlifedata.com/resource/pubmed/id/12386970
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2002-10-21
|
pubmed:abstractText |
CD5+ diffuse large B-cell lymphoma(CD5+DLBCL) is known to have different characteristics than CD5-DLBCL and mantle cell lymphoma(MCL). 9 patients with CD5+DLBCL were reviewed, and the results were compared with those of 8 CD5-DLBCL and 3 cyclin D1+MCL patients. CD5+DLBCL was more closely related to many aggressive clinical features or parameters than CD5-DLBCL: 67% of the patients were older than 60 years, 67% with performance status > or = 2, 89% with serum lactate dehydrogenase level higher than normal, 78% with stage III/IV disease at diagnosis, and 78% with more than one extranodal lesion. The overall International Prognostic Index score for the patients with CD5+DLBCL was thus significantly higher than that for those with CD5-DLBCL. Immunophenotypically, CD5+DLBCL was characterized by CD5+CD10-CD19+CD20+CD21-CD23-cyclin D1-phenotype and the predominant expression of surface IgM. Of particular interest is that the survival rate of CD5+DLBCL patients was significantly inferior to that of patients with CD5-DLBCL. To further characterize CD5+DLBCL, we semi-quantified the CD5 expression in DLBCL cells. Our findings suggest that CD5+DLBCL may constitute a unique subgroup of DLBCL and, moreover, CD5+DLBCL may consist of several subgroups.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0047-1860
|
pubmed:author |
pubmed-author:AraiTakeshiT,
pubmed-author:IshidaToshihikoT,
pubmed-author:KajikawaTatushiT,
pubmed-author:KawakamiKimihiroK,
pubmed-author:KitanakaAkiraA,
pubmed-author:KubotaYoshitsuguY,
pubmed-author:ManabeNorikoN,
pubmed-author:NagaiMasamiM,
pubmed-author:NakaishiHiromiH,
pubmed-author:OhnishiHiroakiH,
pubmed-author:TaminatoTomohikoT,
pubmed-author:TanakaTerukazuT,
pubmed-author:WakiMasatoM,
pubmed-author:YamaokaGenjiG
|
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
906-11
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12386970-Aged,
pubmed-meshheading:12386970-Aged, 80 and over,
pubmed-meshheading:12386970-Antigens, CD5,
pubmed-meshheading:12386970-Female,
pubmed-meshheading:12386970-Flow Cytometry,
pubmed-meshheading:12386970-Humans,
pubmed-meshheading:12386970-Lymphoma, B-Cell,
pubmed-meshheading:12386970-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:12386970-Male,
pubmed-meshheading:12386970-Middle Aged,
pubmed-meshheading:12386970-Prognosis,
pubmed-meshheading:12386970-Survival Rate
|
pubmed:year |
2002
|
pubmed:articleTitle |
[Sub-classification of diffuse large B-cell lymphoma by semi-quantification of the CD5 expression with flow cytometric analysis].
|
pubmed:affiliation |
Department of Medical Technology, Kagawa Prefectural College of Health Sciences, Kida-gun, Kagawapref, 761-0123.
|
pubmed:publicationType |
Journal Article,
English Abstract
|